SCHEMBL5566822

SCHEMBL5566822

NC(=O)c1ccnc(CCl)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.46
POLB P06746 1/20 0.46
KDM5C P41229 4/20 0.45
KDM5B Q9UGL1 3/20 0.45
KDM4C Q9H3R0 2/20 0.45
KDM5A P29375 1/20 0.45
KDM5D Q9BY66 1/20 0.45
KDM4E B2RXH2 1/20 0.45
LMNA P02545 1/20 0.45
CYP3A4 P08684 1/20 0.45
TSHR P16473 1/20 0.45
KDM4B O94953 2/20 0.44
MBOAT4 Q96T53 1/20 0.43
MKNK1 Q9BUB5 1/20 0.41
MKNK2 Q9HBH9 1/20 0.41
PARP10 Q53GL7 1/20 0.41
PARP1 P09874 2/20 0.40
MAP4K4 O95819 2/20 0.40
GABRP O00591 1/20 0.39
GABRD O14764 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5559240 0.83 CYP1A2 (0.40) CYP1A2POLBKDM5CKDM5BKDM4C
SCHEMBL845767 0.83 KDM4C (0.55) KDM5CKDM5BKDM4CKDM5AKDM4E
SCHEMBL31191238 0.83 KDM4C (0.55) KDM5CKDM5BKDM4CKDM5AKDM4E
SCHEMBL30607268 0.83 CYP1A2 (0.47) CYP1A2POLBKDM5CKDM5BKDM4C
SCHEMBL8594535 0.83 CYP1A2 (0.47) CYP1A2POLBKDM5CKDM5BKDM4C
SCHEMBL7668183 0.83 CYP1A2 (0.47) CYP1A2POLBKDM5CKDM5BKDM4C
SCHEMBL509023 0.83 CYP1A2 (0.47) CYP1A2POLBKDM5CKDM5BKDM4C
SCHEMBL28035746 0.82 PARP10 (0.42) CYP1A2POLBKDM5CKDM5BKDM4C
Hydrochloric Acid SCHEMBL4774803 0.81 CYP1A2 (0.39) CYP1A2POLBKDM5CKDM5BKDM4C
SCHEMBL12640033 0.81 CYP1A2 (0.42) CYP1A2POLBKDM5CKDM5BKDM4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1448198-B1 NICOTIN-OR ISONICOTIN BENZOTHIAZOLE DERIVATIVES HOFFMANN LA ROCHE (CH) 2007-10-31 EP disclosed
EP-1448198-A1 NICOTIN-OR ISONICOTIN BENZOTHIAZOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2004-08-25 EP disclosed
US-6620811-B2 Adenosine receptor antagonists; nervous system and cardiovascular disorders; Parkinson*s, Huntington*s, and Alzheimer* disease; antiasthmatics, antiallergens HOFFMANN-LA ROCHE INC. 2003-09-16 US disclosed
US-20030134854-A1 Isonicotin- and nicotinamide derivatives of benzothiazoles F.HOFFMANN-LA ROCHE AG (CH) 2003-07-17 US disclosed
WO-2003043636-A1 NICOTIN-OR ISONICOTIN BENZOTHIAZOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2003-05-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030134854-A1 Isonicotin- and nicotinamide derivatives of benzothiazoles ADORA1, ADORA2A, ADORA3 CYP1A2 437/4885POLB 3097/4885KDM5C 4177/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.